Skip to main content
. 2012 Jan 12;106(4):748–755. doi: 10.1038/bjc.2011.587

Figure 4.

Figure 4

Overall survival of metastatic colorectal cancer patients by AURKA-CN for entire cohort (A), the KRAS wild-type population (B) and the KRAS mutant population (C).